Comprehensive suite of new pre-clinical and clinical testing capabilities: pharmacokinetic (PK), pharmacodynamic (PD), and companion diagnostic (CDx) services.
Proteomics International stands behind the quality, timeliness and reliability of its services. If results are not delivered on time and do not comply with international recognised regulatory standards, charges may not apply.
Proteomics International is ISO/IEC 17025 accredited and operates in accordance with the OECD Principles of Good Laboratory Practice (GLP).
Proteomics International delivers quick and accurate pharmacokinetic results, with the ability to deliver results within three days of receiving samples upon request.
The Australian Government’s Research & Development Tax Incentive offers significant benefits to carrying out research in Australia. Eligible companies could recover as much as 43.5% of every dollar spent on research and development.
Proteomics International can refer you to tax advisors who can facilitate simple and cost-effective access to the R&D Tax Incentive.